JP2014511869A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014511869A5 JP2014511869A5 JP2014504251A JP2014504251A JP2014511869A5 JP 2014511869 A5 JP2014511869 A5 JP 2014511869A5 JP 2014504251 A JP2014504251 A JP 2014504251A JP 2014504251 A JP2014504251 A JP 2014504251A JP 2014511869 A5 JP2014511869 A5 JP 2014511869A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazole
- carboxamide
- pyrimidin
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 29
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 16
- 125000000623 heterocyclic group Chemical group 0.000 claims 13
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 10
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 10
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 9
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 150000002431 hydrogen Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- YNJNLGYPTQPTPW-UHFFFAOYSA-N 1-(6-methoxypyridin-3-yl)-5-pyrimidin-4-ylpyrazole-3-carboxylic acid Chemical compound C1=NC(OC)=CC=C1N1C(C=2N=CN=CC=2)=CC(C(O)=O)=N1 YNJNLGYPTQPTPW-UHFFFAOYSA-N 0.000 claims 1
- YIGPUXRGBBZKJW-UHFFFAOYSA-N 1-tert-butyl-5-(2-methoxypyrimidin-4-yl)pyrazole-3-carboxamide Chemical compound COC1=NC=CC(C=2N(N=C(C=2)C(N)=O)C(C)(C)C)=N1 YIGPUXRGBBZKJW-UHFFFAOYSA-N 0.000 claims 1
- RFJQYCNMCJJJSG-UHFFFAOYSA-N 1-tert-butyl-5-(2-methylsulfanylpyrimidin-4-yl)pyrazole-3-carboxamide Chemical compound CSC1=NC=CC(C=2N(N=C(C=2)C(N)=O)C(C)(C)C)=N1 RFJQYCNMCJJJSG-UHFFFAOYSA-N 0.000 claims 1
- NPAPHHQDTZZLSK-UHFFFAOYSA-N 1-tert-butyl-5-(2-morpholin-4-ylpyrimidin-4-yl)-n-phenylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC=2C=CC=CC=2)C=C1C(N=1)=CC=NC=1N1CCOCC1 NPAPHHQDTZZLSK-UHFFFAOYSA-N 0.000 claims 1
- LLSIYQYYVAAHEN-UHFFFAOYSA-N 1-tert-butyl-5-(2-phenoxypyrimidin-4-yl)-n-phenylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC=2C=CC=CC=2)C=C1C(N=1)=CC=NC=1OC1=CC=CC=C1 LLSIYQYYVAAHEN-UHFFFAOYSA-N 0.000 claims 1
- VZYACGCYABUZMD-UHFFFAOYSA-N 1-tert-butyl-5-(2-phenoxypyrimidin-4-yl)-n-propan-2-ylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC(C)C)C=C1C1=CC=NC(OC=2C=CC=CC=2)=N1 VZYACGCYABUZMD-UHFFFAOYSA-N 0.000 claims 1
- XWSQCSJHYIBIPB-UHFFFAOYSA-N 1-tert-butyl-5-(2-phenylpyrimidin-4-yl)pyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(N)=O)C=C1C1=CC=NC(C=2C=CC=CC=2)=N1 XWSQCSJHYIBIPB-UHFFFAOYSA-N 0.000 claims 1
- NXUZHSNCDIAGAY-UHFFFAOYSA-N 1-tert-butyl-5-[2-(4-cyanophenoxy)pyrimidin-4-yl]-n-methylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC)C=C1C1=CC=NC(OC=2C=CC(=CC=2)C#N)=N1 NXUZHSNCDIAGAY-UHFFFAOYSA-N 0.000 claims 1
- DMLNFHDCCVVACO-UHFFFAOYSA-N 1-tert-butyl-5-[2-(4-cyanophenoxy)pyrimidin-4-yl]-n-phenylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC=2C=CC=CC=2)C=C1C(N=1)=CC=NC=1OC1=CC=C(C#N)C=C1 DMLNFHDCCVVACO-UHFFFAOYSA-N 0.000 claims 1
- GLOLZXJNFUHZRR-UHFFFAOYSA-N 1-tert-butyl-5-[2-(4-cyanophenoxy)pyrimidin-4-yl]-n-propan-2-ylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC(C)C)C=C1C1=CC=NC(OC=2C=CC(=CC=2)C#N)=N1 GLOLZXJNFUHZRR-UHFFFAOYSA-N 0.000 claims 1
- AXRBYRBXIFSKIF-UHFFFAOYSA-N 1-tert-butyl-5-[2-(4-piperazin-1-ylphenoxy)pyrimidin-4-yl]pyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(N)=O)C=C1C1=CC=NC(OC=2C=CC(=CC=2)N2CCNCC2)=N1 AXRBYRBXIFSKIF-UHFFFAOYSA-N 0.000 claims 1
- JPXVJHYKCAPQRA-UHFFFAOYSA-N 1-tert-butyl-5-[2-(dimethylamino)pyrimidin-4-yl]-n-methylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC)C=C1C1=CC=NC(N(C)C)=N1 JPXVJHYKCAPQRA-UHFFFAOYSA-N 0.000 claims 1
- JGLZQEWJZMTROM-UHFFFAOYSA-N 1-tert-butyl-5-[2-(dimethylamino)pyrimidin-4-yl]-n-phenylpyrazole-3-carboxamide Chemical compound CN(C)C1=NC=CC(C=2N(N=C(C=2)C(=O)NC=2C=CC=CC=2)C(C)(C)C)=N1 JGLZQEWJZMTROM-UHFFFAOYSA-N 0.000 claims 1
- KHJXLLUKAIABND-UHFFFAOYSA-N 1-tert-butyl-5-[2-(dimethylamino)pyrimidin-4-yl]-n-propan-2-ylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC(C)C)C=C1C1=CC=NC(N(C)C)=N1 KHJXLLUKAIABND-UHFFFAOYSA-N 0.000 claims 1
- STVXWMPMCBWAQK-UHFFFAOYSA-N 1-tert-butyl-5-[2-(dimethylamino)pyrimidin-4-yl]pyrazole-3-carboxamide Chemical compound CN(C)C1=NC=CC(C=2N(N=C(C=2)C(N)=O)C(C)(C)C)=N1 STVXWMPMCBWAQK-UHFFFAOYSA-N 0.000 claims 1
- PMVLFBLYAWKVTH-UHFFFAOYSA-N 1-tert-butyl-n-methyl-5-(2-phenoxypyrimidin-4-yl)pyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NC)C=C1C1=CC=NC(OC=2C=CC=CC=2)=N1 PMVLFBLYAWKVTH-UHFFFAOYSA-N 0.000 claims 1
- NWLNDDCQBDCBGL-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]-5-(2-methylpyrimidin-4-yl)pyrazole-3-carboxamide Chemical compound COC1=CC=CC(CN2C(=CC(=N2)C=2N=C(C)N=CC=2)C(N)=O)=C1 NWLNDDCQBDCBGL-UHFFFAOYSA-N 0.000 claims 1
- GNDPCMBWJSMFDH-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]-5-(2-oxo-1h-pyrimidin-6-yl)pyrazole-3-carboxamide Chemical compound COC1=CC=CC(CN2C(=CC(=N2)C=2N=C(O)N=CC=2)C(N)=O)=C1 GNDPCMBWJSMFDH-UHFFFAOYSA-N 0.000 claims 1
- -1 2-phenoxypyrimidin-4-yl Chemical group 0.000 claims 1
- SAZWNKNJUWDIKE-UHFFFAOYSA-N 3-(2-methylsulfanylpyrimidin-4-yl)-1h-pyrazole-5-carboxamide Chemical compound CSC1=NC=CC(C=2NN=C(C=2)C(N)=O)=N1 SAZWNKNJUWDIKE-UHFFFAOYSA-N 0.000 claims 1
- LPPNOCWWUZTIKG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-1-(5-chloro-2-ethylphenyl)pyrazole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1N1C(C=2N=C(N)N=CC=2)=CC(C(N)=O)=N1 LPPNOCWWUZTIKG-UHFFFAOYSA-N 0.000 claims 1
- HOURAQDXNPRUJS-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-1-(5-chloro-2-methylphenyl)pyrazole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1N1C(C=2N=C(N)N=CC=2)=CC(C(N)=O)=N1 HOURAQDXNPRUJS-UHFFFAOYSA-N 0.000 claims 1
- ZYDBWXADPWQAMI-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)pyrazole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1N1C(C(N)=O)=CC(C=2N=C(N)N=CC=2)=N1 ZYDBWXADPWQAMI-UHFFFAOYSA-N 0.000 claims 1
- MGCJYRVJINHYAP-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)pyrazole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1N1C(C(N)=O)=CC(C=2N=C(N)N=CC=2)=N1 MGCJYRVJINHYAP-UHFFFAOYSA-N 0.000 claims 1
- IFXSYLKWEVEJIA-UHFFFAOYSA-N 5-(2-methylsulfanylpyrimidin-4-yl)-1-piperidin-4-ylpyrazole-3-carboxamide Chemical compound CSC1=NC=CC(C=2N(N=C(C=2)C(N)=O)C2CCNCC2)=N1 IFXSYLKWEVEJIA-UHFFFAOYSA-N 0.000 claims 1
- OHTRSASACJDQCI-UHFFFAOYSA-N 5-(2-methylsulfanylpyrimidin-4-yl)-2-piperidin-4-ylpyrazole-3-carboxamide Chemical compound CSC1=NC=CC(C2=NN(C(C(N)=O)=C2)C2CCNCC2)=N1 OHTRSASACJDQCI-UHFFFAOYSA-N 0.000 claims 1
- LXAHIOJOUKGSMV-UHFFFAOYSA-N 5-[2-(4-bromo-2-methoxyanilino)pyrimidin-4-yl]-n-(2,6-diethylphenyl)-1-[(4-methoxyphenyl)methyl]pyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(CC=2C=CC(OC)=CC=2)C(C=2N=C(NC=3C(=CC(Br)=CC=3)OC)N=CC=2)=C1 LXAHIOJOUKGSMV-UHFFFAOYSA-N 0.000 claims 1
- WBRIZQWMKIXWSK-UHFFFAOYSA-N 5-[2-(4-bromo-2-methoxyanilino)pyrimidin-4-yl]-n-(2,6-diethylphenyl)-1-methylpyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(C)C(C=2N=C(NC=3C(=CC(Br)=CC=3)OC)N=CC=2)=C1 WBRIZQWMKIXWSK-UHFFFAOYSA-N 0.000 claims 1
- SXSDYPDWRFRBOK-UHFFFAOYSA-N 5-[2-(4-bromo-2-methoxyanilino)pyrimidin-4-yl]-n-(2,6-diethylphenyl)-2-[(4-methoxyphenyl)methyl]pyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=CC(C=2N=C(NC=3C(=CC(Br)=CC=3)OC)N=CC=2)=NN1CC1=CC=C(OC)C=C1 SXSDYPDWRFRBOK-UHFFFAOYSA-N 0.000 claims 1
- SIYHLKJVZNBAAO-UHFFFAOYSA-N 5-[2-(4-bromo-2-methoxyanilino)pyrimidin-4-yl]-n-(2,6-diethylphenyl)-2-methylpyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=CC(C=2N=C(NC=3C(=CC(Br)=CC=3)OC)N=CC=2)=NN1C SIYHLKJVZNBAAO-UHFFFAOYSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- JPKZTKMCHHNHCK-UHFFFAOYSA-N N-hydroxy-3-(2-methylsulfanylpyrimidin-4-yl)-1H-pyrazole-5-carboxamide Chemical compound CSC1=NC=CC(C=2NN=C(C=2)C(=O)NO)=N1 JPKZTKMCHHNHCK-UHFFFAOYSA-N 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- YNEYAILCVWIGMT-UHFFFAOYSA-N [1-(6-methoxypyridin-3-yl)-5-pyrimidin-4-ylpyrazol-3-yl]-(4-methylpiperazin-1-yl)methanone Chemical compound C1=NC(OC)=CC=C1N1C(C=2N=CN=CC=2)=CC(C(=O)N2CCN(C)CC2)=N1 YNEYAILCVWIGMT-UHFFFAOYSA-N 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 238000011319 anticancer therapy Methods 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- VRDMGEJYLOAERF-UHFFFAOYSA-N methyl 1-(6-methoxypyridin-3-yl)-5-(2-methylsulfanylpyrimidin-4-yl)pyrazole-3-carboxylate Chemical compound C=1C=C(OC)N=CC=1N1N=C(C(=O)OC)C=C1C1=CC=NC(SC)=N1 VRDMGEJYLOAERF-UHFFFAOYSA-N 0.000 claims 1
- NPDWZVIWNJMPPR-UHFFFAOYSA-N methyl 1-(6-methoxypyridin-3-yl)-5-pyrimidin-4-ylpyrazole-3-carboxylate Chemical compound C=1C=C(OC)N=CC=1N1N=C(C(=O)OC)C=C1C1=CC=NC=N1 NPDWZVIWNJMPPR-UHFFFAOYSA-N 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- ANWOMOBMTBNCGP-UHFFFAOYSA-N n-(2,6-diethylphenyl)-3-[2-(2-methoxyanilino)pyrimidin-4-yl]-1h-pyrazole-5-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NNC(C=2N=C(NC=3C(=CC=CC=3)OC)N=CC=2)=C1 ANWOMOBMTBNCGP-UHFFFAOYSA-N 0.000 claims 1
- GXEHCAYTZFZPQF-UHFFFAOYSA-N n-(2,6-diethylphenyl)-3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1h-pyrazole-5-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NNC(C=2N=C(NC=3C(=CC(=CC=3)N3CCN(C)CC3)OC)N=CC=2)=C1 GXEHCAYTZFZPQF-UHFFFAOYSA-N 0.000 claims 1
- LNSLVWVMNZJSHN-UHFFFAOYSA-N n-(2,6-diethylphenyl)-3-[2-[4-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]-1h-pyrazole-5-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NNC(C=2N=C(NC=3C(=CC(=CC=3)N3CCN(CCO)CC3)OC)N=CC=2)=C1 LNSLVWVMNZJSHN-UHFFFAOYSA-N 0.000 claims 1
- UTWAVTYOSXACBH-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-(2-methoxyanilino)pyrimidin-4-yl]-1-[(4-methoxyphenyl)methyl]pyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(CC=2C=CC(OC)=CC=2)C(C=2N=C(NC=3C(=CC=CC=3)OC)N=CC=2)=C1 UTWAVTYOSXACBH-UHFFFAOYSA-N 0.000 claims 1
- HVTSGLCSESUTKX-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-(2-methoxyanilino)pyrimidin-4-yl]-1-methylpyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(C)C(C=2N=C(NC=3C(=CC=CC=3)OC)N=CC=2)=C1 HVTSGLCSESUTKX-UHFFFAOYSA-N 0.000 claims 1
- AIXGHQIUKRVEAX-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-(2-methoxyanilino)pyrimidin-4-yl]-2-[(4-methoxyphenyl)methyl]pyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=CC(C=2N=C(NC=3C(=CC=CC=3)OC)N=CC=2)=NN1CC1=CC=C(OC)C=C1 AIXGHQIUKRVEAX-UHFFFAOYSA-N 0.000 claims 1
- LPNFVFRZLDAJHS-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-[(4-methoxyphenyl)methyl]pyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(CC=2C=CC(OC)=CC=2)C(C=2N=C(NC=3C(=CC(=CC=3)N3CCN(C)CC3)OC)N=CC=2)=C1 LPNFVFRZLDAJHS-UHFFFAOYSA-N 0.000 claims 1
- WZKSKKZREXLPGE-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylpyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(C)C(C=2N=C(NC=3C(=CC(=CC=3)N3CCN(C)CC3)OC)N=CC=2)=C1 WZKSKKZREXLPGE-UHFFFAOYSA-N 0.000 claims 1
- YFPXKALYLATDPX-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]-2-methylpyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=CC(C=2N=C(NC=3C(=CC(=CC=3)N3CCN(C)CC3)OC)N=CC=2)=NN1C YFPXKALYLATDPX-UHFFFAOYSA-N 0.000 claims 1
- ZFRAYIYRRCRCJI-UHFFFAOYSA-N n-(2,6-diethylphenyl)-5-[2-[4-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]-1-methylpyrazole-3-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=NN(C)C(C=2N=C(NC=3C(=CC(=CC=3)N3CCN(CCO)CC3)OC)N=CC=2)=C1 ZFRAYIYRRCRCJI-UHFFFAOYSA-N 0.000 claims 1
- WYBUJUAJMUSILH-UHFFFAOYSA-N n-benzyl-1-tert-butyl-5-(2-phenoxypyrimidin-4-yl)pyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NCC=2C=CC=CC=2)C=C1C(N=1)=CC=NC=1OC1=CC=CC=C1 WYBUJUAJMUSILH-UHFFFAOYSA-N 0.000 claims 1
- IUPQGRJRSIZORG-UHFFFAOYSA-N n-benzyl-1-tert-butyl-5-[2-(4-cyanophenoxy)pyrimidin-4-yl]pyrazole-3-carboxamide Chemical compound CC(C)(C)N1N=C(C(=O)NCC=2C=CC=CC=2)C=C1C(N=1)=CC=NC=1OC1=CC=C(C#N)C=C1 IUPQGRJRSIZORG-UHFFFAOYSA-N 0.000 claims 1
- KXJJQDWQTVXFCT-UHFFFAOYSA-N n-benzyl-1-tert-butyl-5-[2-(dimethylamino)pyrimidin-4-yl]pyrazole-3-carboxamide Chemical compound CN(C)C1=NC=CC(C=2N(N=C(C=2)C(=O)NCC=2C=CC=CC=2)C(C)(C)C)=N1 KXJJQDWQTVXFCT-UHFFFAOYSA-N 0.000 claims 1
- XMKDCEXITJWDAL-UHFFFAOYSA-N n-tert-butyl-1-(6-methoxypyridin-3-yl)-5-pyrimidin-4-ylpyrazole-3-carboxamide Chemical compound C1=NC(OC)=CC=C1N1C(C=2N=CN=CC=2)=CC(C(=O)NC(C)(C)C)=N1 XMKDCEXITJWDAL-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11161925.0 | 2011-04-11 | ||
| EP11161925 | 2011-04-11 | ||
| PCT/EP2012/056047 WO2012139930A1 (en) | 2011-04-11 | 2012-04-03 | Pyrazolyl-pyrimidine derivatives as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014511869A JP2014511869A (ja) | 2014-05-19 |
| JP2014511869A5 true JP2014511869A5 (cg-RX-API-DMAC10.html) | 2015-05-21 |
| JP5976778B2 JP5976778B2 (ja) | 2016-08-24 |
Family
ID=46022177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014504251A Expired - Fee Related JP5976778B2 (ja) | 2011-04-11 | 2012-04-03 | キナーゼ阻害剤としてのピラゾリル−ピリミジン誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9284298B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2702055A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5976778B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2012139930A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| JO3215B1 (ar) | 2012-08-09 | 2018-03-08 | Phenex Pharmaceuticals Ag | حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy |
| US9206136B2 (en) * | 2013-01-10 | 2015-12-08 | Grünenthal GmbH | Pyrazolyl-based carboxamides I |
| BR112015016394A2 (pt) | 2013-01-10 | 2017-07-11 | Gruenenthal Gmbh | carboxamidas ii baseadas em pirazolil como inibidoras do canal crac |
| ES2649156T3 (es) | 2013-01-14 | 2018-01-10 | Incyte Holdings Corporation | Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim |
| TW201932456A (zh) | 2013-01-15 | 2019-08-16 | 美商英塞特控股公司 | 適用作pim激酶抑制劑之噻唑甲醯胺及吡啶甲醯胺化合物 |
| KR102502937B1 (ko) * | 2013-03-15 | 2023-02-23 | 사이클리온 테라퓨틱스, 인크. | ｓＧＣ 자극인자 |
| JP2016514718A (ja) * | 2013-03-21 | 2016-05-23 | バイエル ファーマ アクチエンゲゼルシャフト | ３−ヘテロアリール置換インダゾール類 |
| CN105473570A (zh) * | 2013-06-21 | 2016-04-06 | 拜耳制药股份公司 | 二氨基杂芳基取代的吡唑 |
| HK1223097A1 (zh) * | 2013-06-21 | 2017-07-21 | Bayer Pharma Aktiengesellschaft | 杂芳基取代的吡唑 |
| MX2016002367A (es) | 2013-08-23 | 2016-10-28 | Incyte Corp | Compuestos de carboxamida de furo y tienopiridina utiles como inhibidores de cinasas pim. |
| MY199131A (en) | 2014-03-07 | 2023-10-17 | Biocryst Pharm Inc | Human plasma kallikrein inhibitors |
| WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| EP3283642B1 (en) | 2015-04-17 | 2023-10-11 | Netherlands Translational Research Center Holding B.V. | Prognostic biomarkers for ttk inhibitor chemotherapy |
| WO2016187324A1 (en) * | 2015-05-18 | 2016-11-24 | Td2, Inc. | Heterocyclic compounds as kinase inhibitors |
| US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
| WO2017011776A1 (en) | 2015-07-16 | 2017-01-19 | Array Biopharma, Inc. | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
| TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Ｐｉｍ激酶抑制劑之鹽 |
| US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| EP3368039A1 (en) | 2015-10-26 | 2018-09-05 | The Regents of The University of Colorado, A Body Corporate | Point mutations in trk inhibitor-resistant cancer and methods relating to the same |
| WO2017157991A1 (en) * | 2016-03-18 | 2017-09-21 | Bayer Pharma Aktiengesellschaft | 1-alkyl-pyrazoles and -indazoles as bub1 inhibitors for the treatment of hyperproliferative diseases |
| US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
| LT3439663T (lt) | 2016-04-04 | 2024-10-10 | Loxo Oncology, Inc. | Vaikų vėžio gydymo būdai |
| HUE068971T2 (hu) | 2016-04-04 | 2025-02-28 | Loxo Oncology Inc | (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-A]pirimidin-3-il) -3-hidroxipirrolidin-1-karboxamid folyékony készítményei |
| PT3800189T (pt) | 2016-05-18 | 2023-07-27 | Array Biopharma Inc | Preparação de (s)-n-(5-((r)-2-(2,5- difluoropenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3- il)-3-hidroxipirrolidina-1-carboxamida |
| TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
| JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
| JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
| AU2017362571A1 (en) * | 2016-11-21 | 2019-07-11 | Translational Drug Development, Llc | Heterocyclic compounds as kinase inhibitors |
| WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
| CN110267960B (zh) | 2017-01-18 | 2022-04-26 | 阿雷生物药品公司 | 作为RET激酶抑制剂的取代的吡唑并[1,5-a]吡嗪化合物 |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| WO2018207881A1 (ja) * | 2017-05-12 | 2018-11-15 | 武田薬品工業株式会社 | 複素環化合物 |
| CN109516955B (zh) * | 2017-09-20 | 2022-07-26 | 华东师范大学 | 含氮五元芳香杂环化合物及其制备方法和应用 |
| TWI876442B (zh) | 2017-10-10 | 2025-03-11 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
| TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
| US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| CA3087972C (en) | 2018-01-18 | 2023-01-10 | Array Biopharma Inc. | Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors |
| US11603374B2 (en) | 2018-01-18 | 2023-03-14 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| EP3740490A1 (en) | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors |
| CN108309959A (zh) * | 2018-02-06 | 2018-07-24 | 宁波新靶生物医药科技有限公司 | N或o或c-二芳基取代衍生物的合成及其药学应用 |
| CN110372664A (zh) * | 2018-04-13 | 2019-10-25 | 华东理工大学 | 选择性jak2抑制剂及其应用 |
| WO2020028258A1 (en) | 2018-07-31 | 2020-02-06 | Loxo Oncology, Inc. | Spray-dried dispersions and formulations of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoro propan-2-yl)-1h-pyrazole-4-carboxamide |
| CN112996794A (zh) | 2018-09-10 | 2021-06-18 | 阿雷生物药品公司 | 作为ret激酶抑制剂的稠合杂环化合物 |
| CN111072582B (zh) * | 2018-10-18 | 2024-06-18 | 中国药科大学 | 一种n－羟基芳杂环－2－甲酰胺化合物及其制备方法和用途 |
| EP3898615A1 (en) | 2018-12-19 | 2021-10-27 | Array Biopharma, Inc. | 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer |
| US12180207B2 (en) | 2018-12-19 | 2024-12-31 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases |
| EP4069369A4 (en) | 2019-12-06 | 2024-02-14 | Schrödinger, Inc. | CYCLIC COMPOUNDS AND METHODS OF USE THEREOF |
| US20240018157A1 (en) | 2019-12-27 | 2024-01-18 | Schrödinger, Inc. | Cyclic compounds and methods of using same |
| CA3171979A1 (en) * | 2020-03-27 | 2021-09-30 | Josep Bassaganya-Riera | Plxdc2 ligands |
| EP4210694B1 (en) * | 2020-09-10 | 2025-10-15 | Merck Sharp & Dohme LLC | Plasma kallikrein inhibitors |
| JP2023541047A (ja) | 2020-09-10 | 2023-09-27 | シュレーディンガー， インコーポレイテッド | がんの治療のための複素環式ペリ縮環ｃｄｃ７キナーゼ阻害剤 |
| US20240285621A1 (en) | 2020-09-23 | 2024-08-29 | Nerviano Medical Sciences S.R.L. | Pyrazolyl-pyrimidine derivatives as kinase inhibitors |
| JP7613778B2 (ja) * | 2020-11-26 | 2025-01-15 | 科輝智薬（深▲セン▼）新薬研究中心有限公司 | アミド化合物、医薬組成物およびその使用 |
| EP4284804A1 (en) | 2021-01-26 | 2023-12-06 | Schrödinger, Inc. | Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders |
| TW202300150A (zh) | 2021-03-18 | 2023-01-01 | 美商薛定諤公司 | 環狀化合物及其使用方法 |
| CN114957261B (zh) * | 2022-05-17 | 2023-06-23 | 重庆文理学院 | 一种具有抗头颈癌作用的化合物及其制备方法和应用 |
| WO2024059524A1 (en) * | 2022-09-12 | 2024-03-21 | Hotspot Therapeutics, Inc. | Pyrazolylcarboxamide compounds and their use in therapy |
| WO2025059027A1 (en) | 2023-09-11 | 2025-03-20 | Schrödinger, Inc. | Cyclopenta[e]pyrazolo[1,5-a]pyrimidine derivatives as malt1 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109204B2 (en) * | 2001-08-01 | 2006-09-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| BRPI0413438A (pt) | 2003-08-08 | 2006-10-17 | Pharmacia Italia Spa | derivados de pirimidilpirrol ativos como inibidores de cinase |
| TW200526641A (en) * | 2003-12-26 | 2005-08-16 | Daiichi Seiyaku Co | Amidopyrazole derivatives |
| JPWO2006014005A1 (ja) | 2004-08-06 | 2008-05-01 | 第一製薬株式会社 | ピラゾール誘導体 |
| WO2006071644A1 (en) | 2004-12-23 | 2006-07-06 | Vertex Pharmaceuticals Incorporated | Selective inhibitors of erk protein kinases and uses therof |
| US8263604B2 (en) | 2006-03-27 | 2012-09-11 | Nerviano Medical Sciences S.R.L. | Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| KR101580482B1 (ko) * | 2007-11-16 | 2015-12-28 | 인사이트 홀딩스 코포레이션 | 야누스 키나제 억제제로서의 ４－피라졸릴－ｎ－아릴피리미딘－２－아민 및 ４－피라졸릴－ｎ－헤테로아릴피리미딘－２－아민 |
| JP5542133B2 (ja) * | 2008-06-26 | 2014-07-09 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | ピラゾロ−キナゾリン |
| AU2010211672B2 (en) * | 2009-02-06 | 2016-08-04 | Nippon Shinyaku Co., Ltd. | Aminopyrazine derivative and medicine |
| WO2010108921A1 (en) * | 2009-03-27 | 2010-09-30 | Nerviano Medical Sciences S.R.L. | N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
-
2012
- 2012-04-03 EP EP12717627.9A patent/EP2702055A1/en not_active Withdrawn
- 2012-04-03 WO PCT/EP2012/056047 patent/WO2012139930A1/en not_active Ceased
- 2012-04-03 US US14/110,596 patent/US9284298B2/en active Active
- 2012-04-03 JP JP2014504251A patent/JP5976778B2/ja not_active Expired - Fee Related